INDIA, BANGALORE: Onco Treatments, a completely possessed additional of pharmaceutical company Progress Arcolab, has obtained two US FDA (Food and Medication Administration) mortgage approvals for ‘Fluorouracil Hypodermic injection USP’.
Fluorouracil is part of the oncology collection certified to Pfizer for the US industry and predicted to be released soon, a media declaration said.
Fluorouracil is a radiation treatment drug which inhibits tissues making DNA and RNA, and prevents the development of cancer malignancy tissues. It is used to cure several types of cancer malignancy such as digestive tract, anal sphincter, and head and throat malignancies.
According to the declaration, Fluorouracil is among the products in the drug lack list of USFDA. According to IMS data, the US industry for general Fluorouracil is roughly $14 thousand.
No comments:
Post a Comment